tert-Butylhydroquinone Treatment Alleviates Contrast-Induced Nephropathy in Rats by Activating the Nrf2/Sirt3/SOD2 Signaling Pathway

Figure 9

The efficacy of the Nrf2 knockdown by siRNA was measured by western blot.